the aid library

LIST OPTIONS

Filter

357

Sort by:

Direction:

Download (67)

View PDF (129)

Patient Navigator Training Collaborative

Patient Navigator Training Collaborative (2021) CC

Navigate to new knowledge and skills.

Download (98)

View PDF (154)

Patient Navigator Daily Routine

Kilimanjaro Christian Medical Centre (2021) CC

SOP for Patient Navigator Daily Routine

Download (109)

View PDF (131)

Patient Navigator - Job Discription

Kilimanjaro Christian Medical Centre (2021) CC

Download (39)

View PDF (1108)

eLearning Courses for navigation professionals

Patient Navigator Training Collaborative (2021) CC

Our eLearning Courses were created just for navigation professionals. They are self-paced and interactive. Learn more about patient navigation, chronic disease, and how to help your clients get the care they need and live healthier lives. Leave a course and come back any time. Certificates of compl... more

Download (23)

View PDF (308)

Navigation & the Healthcare System Course

University of Colorado (2018) CC

Patient Navigator & Community Health Worker Training. This course is organized into three modules that describe patient navigation’s role in reducing health disparities and improving treatment for chronic diseases.

Download (192)

View PDF (2086)

LIFE: Neonatal Resuscitation Training (ETAT+ NR). App

Nuffield Department of Medicine (2019) CC

Learn the ETAT+ guidelines on how to resuscitate a newborn baby who is born not breathing in this exciting 3D simulation training app. Navigate around a virtual reality hospital, find the equipment you need and quiz yourself with interactive quizzes, multiple-choice questions (MCQs) and perform simu... more

Download (32)

View PDF (801)

Patient brochure about antibiotic resistance

European Centre for Disease Prevention and Control (2019) C_CDC

A patient leaflet for primary care prescribers to hand out to patients: it explains to patients what antibiotic resistance is and why appropriate use of antibiotics is important.

Download (43)

View PDF (753)

Oncology Patient Navigation Training: Results of a Pilot Study in Nigeria

Chidebe, R.C.W., and M.L. Pratt-Chapman (2021) CC

Journal of Cancer Education https://doi.org/10.1007/s13187-020-01935-7

Download (82)

View PDF (137)

Patient safety assessment manual
recommended

World Health Organization WHO (2022) C_WHO

3rd edition. Patient safety standards are critical for the establishment and assessment of patient safety programmes within hospitals. This third edition of the Patient safety assessment manual provides an updated set of standards and assessment criteria that reflect current best practice and WHO gu... more

Download (215)

View PDF (261)

Ethics in epidemics, emergencies and disasters: research, surveillance and patient care: training manual

World Health Organization (WHO) (2015) C_WHO

Responses to epidemics, emergencies and disasters raise many ethical issues for the people involved, including public health specialists and policy makers. This training manual provides material on ethical issues in research, surveillance and patient care in these difficult contexts.

Download (394)

View PDF (912)

Linking Private Primary Health Care Networks to Sustainable Domestic Financing: A Practical Guide for Network Managers

Hariharan, N., Ishtiaq, A., Eldridge, C., et al. Results for Development (R4D) (2018) C1

The guide helps network managers and technical experts navigate the steps necessary for gathering, structuring, analyzing and reporting information needed to make strategic plans that improve sustainability and equity.

Download (85)

View PDF (90)

Synthesized Guidance For COVID-19 Message Development

John Hopkins Bloomberg School (2020) CC

As information about COVID-19 is rapidly evolving, it can be challenging to navigate and synthesize all of the information. The purpose of this document is to provide a synthesized, indexed reference of accurate, standardized COVID-19 information from trustworthy sources. Information is presented in... more

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Patient safety assessment manual recommended

Patient safety assessment manual
recommended